Clinical Trial Update: To Evaluate Immunogenicity & Safety of GSK Bio's DTPa-HBV-IPV/Hib (Mixed Vaccine) and DTPa-IPV/Hib + HBV Vaccines [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the immunogenicity and safety of GlaxoSmithKline's DTPa-HBV-IPV/Hib mixed vaccine and DTPa-IPV/Hib + HBV vaccines in Hepatitis B, with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• DTPa-HBV-IPV/Hib (Mixed Vaccine) (DTPa-HBV-IPV/Hib)
• DTPa-IPV/Hib + HBV Vaccine (DTPa-IPV/Hib + HBV)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Phase 3 | Status: COMPLETED